Guidelines for older adults with diabetes mention that sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists might have favourable effects on cognition [6] based on a network meta-analysis [7]. This evidence concerns the gene SLC5A2 and diabetes mellitus.